ISSN 0303-5212
 

Original Research 
RMJ. 2016; 41(3): 280-282


Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan

Shazia Siddiq, Faiza Batool, Kausar Malik.

Abstract
Objectives: To observe hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan.
Methodology: This descriptive study was conducted at the Department of Medicine, Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan over a period of 2 years. It included 100 patients with chronic hepatitis C and laboratory investigations like blood complete picture, liver function tests (LFTs), Quantitative PCR for HCV RNA and ultrasound abdomen were reviewed. Combination therapy with pegylated interferon alpha 2a and ribavirin was started and patients progress was monitored for 6 months. Their blood complete picture was repeated at 2 weeks, 4 weeks and then on monthly basis for six months.
Results: Out of 100 patients, 68 were females and 32 were male. Mean age was 43 years. Mean hemoglobin, white blood cells (WBC) and platelets before treatment were 12.4 g/dl, 6.8 x 103/mcL and 210 x 103/mcL, respectively. Mean WBC kept on decreasing until 3 months and then improved and at end of treatment were 5.6 x 103/mcL. Similar trend was seen in hemoglobin with mean hemoglobin 11 g/dl at 6 months. Mean platelets at 6 months were 199 x 103/mc (P<0.05).
Conclusion: Combination therapy with pegylated interferon alpha 2a and ribavirin was associated hematological side effects

Key words: Hematological side effects, pegylated interferon alpha 2a, ribavirin, hepatitis C


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Shazia Siddiq
Articles by Faiza Batool
Articles by Kausar Malik
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Shazia Siddiq, Faiza Batool, Kausar Malik. Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. RMJ. 2016; 41(3): 280-282.


Web Style

Shazia Siddiq, Faiza Batool, Kausar Malik. Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. https://www.rmj.org.pk/?mno=216651 [Access: December 05, 2023].


AMA (American Medical Association) Style

Shazia Siddiq, Faiza Batool, Kausar Malik. Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. RMJ. 2016; 41(3): 280-282.



Vancouver/ICMJE Style

Shazia Siddiq, Faiza Batool, Kausar Malik. Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. RMJ. (2016), [cited December 05, 2023]; 41(3): 280-282.



Harvard Style

Shazia Siddiq, Faiza Batool, Kausar Malik (2016) Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. RMJ, 41 (3), 280-282.



Turabian Style

Shazia Siddiq, Faiza Batool, Kausar Malik. 2016. Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. Rawal Medical Journal, 41 (3), 280-282.



Chicago Style

Shazia Siddiq, Faiza Batool, Kausar Malik. "Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan." Rawal Medical Journal 41 (2016), 280-282.



MLA (The Modern Language Association) Style

Shazia Siddiq, Faiza Batool, Kausar Malik. "Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan." Rawal Medical Journal 41.3 (2016), 280-282. Print.



APA (American Psychological Association) Style

Shazia Siddiq, Faiza Batool, Kausar Malik (2016) Hematological side effects of pegylated interferon alpha 2a and ribavirin therapy at Sheikh Khalifa Bin Zaid Hospital, Rawalakot, Pakistan. Rawal Medical Journal, 41 (3), 280-282.